CHL1 suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and Merlin. This evidence concerns the gene CHL1 and nasopharyngeal carcinoma.